Associations of the HER2DX Genomic Test with Biological and Pathological Features in HER2-positive Breast Cancer. Sanfeliu E, Martinez-Romero A, Marin-Aguilera M, Cobo S, et al. Clin Cancer Res 2025 Dec 1. doi: 10.1158/1078-0432.CCR-25-3123.

Read + Share

Amedeo Smart

Independent Medical Education

Sanfeliu E, Martinez-Romero A, Marin-Aguilera M, Cobo S, et al. Associations of the HER2DX Genomic Test with Biological and Pathological Features in HER2-positive Breast Cancer. Clin Cancer Res 2025 Dec 1. doi: 10.1158/1078-0432.CCR-25-3123.
PMID: 41324567